BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18769234)

  • 1. Inflammation and immunity in diabetic vascular complications.
    Nilsson J; Bengtsson E; Fredrikson GN; Björkbacka H
    Curr Opin Lipidol; 2008 Oct; 19(5):519-24. PubMed ID: 18769234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
    Nilsson J; Wigren M; Shah PK
    Trends Cardiovasc Med; 2009 Nov; 19(8):272-6. PubMed ID: 20447570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untangling the role of amyloid in atherosclerosis.
    Howlett GJ; Moore KJ
    Curr Opin Lipidol; 2006 Oct; 17(5):541-7. PubMed ID: 16960503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pathways and therapies in experimental diabetic atherosclerosis.
    Koulis C; de Haan JB; Allen TJ
    Expert Rev Cardiovasc Ther; 2012 Mar; 10(3):323-35. PubMed ID: 22390805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
    Hodgkinson CP; Laxton RC; Patel K; Ye S
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free hemoglobin: a dangerous signal for the immune system in patients with carotid atherosclerosis?
    Buttari B; Profumo E; Petrone L; Pietraforte D; Siracusano A; Margutti P; Delunardo F; Ortona E; Minetti M; Salvati B; Riganò R
    Ann N Y Acad Sci; 2007 Jun; 1107():42-50. PubMed ID: 17804531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).
    Di Marzio D; Mohn A; Mokini ZH; Giannini C; Chiarelli F
    Horm Metab Res; 2006 Nov; 38(11):691-705. PubMed ID: 17111296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation.
    Lundberg AM; Yan ZQ
    Curr Opin Lipidol; 2011 Oct; 22(5):343-9. PubMed ID: 21881501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models for studies of cardiovascular complications of type 1 diabetes.
    Shen X; Bornfeldt KE
    Ann N Y Acad Sci; 2007 Apr; 1103():202-17. PubMed ID: 17376839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity in atherosclerosis: a protective response losing control?
    Nilsson J; Hansson GK
    J Intern Med; 2008 May; 263(5):464-78. PubMed ID: 18410590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
    Nilsson J; Björkbacka H; Fredrikson GN
    Curr Opin Lipidol; 2012 Oct; 23(5):422-8. PubMed ID: 22814703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Lipoproteins, glycoxidation and diabetic angiopathy'.
    Jenkins AJ; Best JD; Klein RL; Lyons TJ
    Diabetes Metab Res Rev; 2004; 20(5):349-68. PubMed ID: 15343582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation-specific epitopes are important targets of innate immunity.
    Chou MY; Hartvigsen K; Hansen LF; Fogelstrand L; Shaw PX; Boullier A; Binder CJ; Witztum JL
    J Intern Med; 2008 May; 263(5):479-88. PubMed ID: 18410591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and neovascularization in diabetic atherosclerosis.
    Purushothaman KR; Meerarani P; Moreno PR
    Indian J Exp Biol; 2007 Jan; 45(1):93-102. PubMed ID: 17249333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes in atherosclerosis.
    Wigren M; Nilsson J; Kolbus D
    Clin Chim Acta; 2012 Oct; 413(19-20):1562-8. PubMed ID: 22565046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic vascular disease: an experimental objective.
    Goldberg IJ; Dansky HM
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1693-701. PubMed ID: 16763160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE and its ligands: a lasting memory in diabetic complications?
    Yan SF; Ramasamy R; Bucciarelli LG; Wendt T; Lee LK; Hudson BI; Stern DM; Lalla E; DU Yan S; Rong LL; Naka Y; Schmidt AM
    Diab Vasc Dis Res; 2004 May; 1(1):10-20. PubMed ID: 16305050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.